Display Settings:

Format

Send to:

Choose Destination
    Inflammopharmacology. 2008 Oct;16(5):248-52.

    The challenge of developing green tea polyphenols as therapeutic agents.

    Source

    Department of Applied Biology and Chemical Technology, The Polytechnic University of Hong Kong, Hung Hom, Hong Kong SAR, China.

    Abstract

    The health benefits of green tea and its main constituent (-)-epigallocatechin gallate [(-)-EGCG] have been widely supported by results from epidemiological, cell culture, animal and clinical studies. On the other hand, there are a number of issues, such as stability, bioavailability and metabolic transformations under physiological conditions, facing the development of green tea polyphenols into therapeutic agents. We previously reported that the synthetic peracetate of (-)-EGCG has improved stability and better bioavailability than (-)-EGCG itself and can act as pro-drug under both in vitro and in vivo conditions. Analogs of catechins have been synthesized and their structure activity relationship provides an understanding to the mechanism of proteasome inhibition. Metabolic methylation of catechins leading to methylated (-)-EGCG may alter the biological activities of these compounds.

    PMID:
    18815735
    [PubMed - indexed for MEDLINE]
    PMCID:
    PMC3306607
    Free PMC Article

    Images from this publication.See all images (2) Free text

    Scheme 1
    Fig. 1

      Supplemental Content

      Icon for Springer Icon for PubMed Central

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk